First patient in OSCAR trial receives GSK’s otilimab in UK
Participants will receive otilimab doses intravenously. Credit: Manchester University NHS Foundation Trust.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more